Browse by Authors and EditorsJump to: Article Number of items: 2. ArticleFlume, Patrick, VanDevanter, Donald R., Morgan, E.E., Dudley, Michael N., Loutit, Jeffery S., Bell, Scott C., Kerem, Eitan, Fischer, R., Smyth, Alan R., Aaron, Shawn D., Conrad, Douglas, Geller, David E. and Elborn, J. Stuart (2016) A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 15 . pp. 495-502. ISSN 1873-5010 Elborn, J. Stuart, Geller, David E., Conrad, Douglas, Aaron, Shawn D., Smyth, Alan R., Fischer, Rainald, Kerem, Eitan, Bell, Scott C., Loutit, Jeffery S., Dudley, Michael N., Morgan, Elizabeth E., VanDevanter, Donald R. and Flume, Patrick (2015) A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients. Journal of Cystic Fibrosis, 14 (4). pp. 507-514. ISSN 1873-5010 |